Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ruilope, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruilope, L. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2004) 19: 524-528
Nephrol Dial Transplant Vol. 19 No. 3 (c) ERA-EDTA 2004; all rights reserved

Editorial Comment

New European guidelines for management of hypertension: what is relevant for the nephrologist

Luis M. Ruilope

Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain

Correspondence and offprint requests to: Luis M. Ruilope, Unidad de Hipertensión, Hospital 12 de Octubre, E-28041 Madrid, Spain. Email: luis_m_ruilope@teleline.es

Keywords: arterial hypertension; cardiovascular risk factors; estimated GFR; microalbuminuria; proteinuria; serum creatinine

The first 150 words of the full text of this article appear below.



   Introduction
 
It is well established among nephrologists that advanced renal failure is associated with an increased prevalence of cardiovascular (CV) disease including myocardial infarction, stroke and heart failure [1]. Recently, a great amount of information has become available, which demonstrates that the finding of minor abnormalities of renal function also predicts more CV risk in the general population, as well as in hypertensive patients [2].

Recently, the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) have published their guidelines for the management of arterial hypertension [3]. This came only a short time after the JNC 7 report had been published [4]. Some of the relevant changes refer to the introduction of new risk factors that have come to complete the list of major CV risk factors. In this sense, both guidelines recognize the relevance of minor abnormalities of renal . . . [Full Text of this Article]



   Detection and prevalence of minor abnormalities of renal function in clinical practice
 


   Microalbuminuria and proteinuria as predictors of CV risk in hypertensive patients
 


   Mechanisms underlying the increase in CV risk
 


   Are minor renal abnormalities preventable and/or correctable?
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?